# Top 50 Life Science VC (Venture Capital) Funds in France in May 2026

## Bpifrance
- Type: VC Fund
- Location: Maisons-alfort, Ile-de-France, France
- Relevant deals: 8
- Stages: Seed, Series A
- Focus: Software, Health Care, Information Technology

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

## Kurma Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

## Omnes Capital
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 5
- Stages: Series A, Series B
- Focus: Software, Biotechnology, Health Care

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

## AdBio partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

## Paca Investissement
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Internet, Manufacturing

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

## Idinvest Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 4
- Stages: Series B, Series A
- Focus: Biotechnology, Software, Health Care

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

## Seventure Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Software

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

## Blue Horizon Corporation
- Type: VC Fund
- Location: Zürich, Zurich, Switzerland
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Food and Beverage, Food Processing, Biotechnology

Our mission is to accelerate the transition to a new Sustainable Food System that delivers outstanding returns for investors and the planet.

## Boehringer Ingelheim Venture Fund
- Type: VC Fund
- Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

## Advent Life Sciences
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Galia Gestion
- Type: VC Fund
- Location: Bordeaux, Aquitaine, France
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Manufacturing, Software, Biotechnology

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

## WiSEED
- Type: VC Fund
- Location: Toulouse, Midi-Pyrenees, France
- Relevant deals: 2
- Stages: Seed, Equity Crowdfunding
- Focus: Software, Manufacturing, Biotechnology

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

## Heartcore Capital
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Software, E-Commerce, Artificial Intelligence

Heartcore Capital is an early-stage venture capital firm devoted to backing founders building category-defining consumer internet brands.Founded as Sunstone Capital in 2007, Heartcore has raised over $500 million in committed capital across four fund generations. The firm has offices in Copenhagen, Berlin, and Paris but invests across Europe andoccasionally in the United States. Heartcore has backed more than 70 exceptional founding teams.

## Thia Ventures
- Type: VC Fund
- Location: Genève, Geneve, Switzerland
- Relevant deals: 2
- Stages: Series A, Seed, Pre-Seed
- Focus: Biotechnology, Health Care, Life Science

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

## Beyond Impact
- Type: VC Fund
- Location: Minneapolis, Minnesota, United States
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Food and Beverage, News, Seafood

A trusted Microsoft Gold Partner, Beyond Impact is uniquely positioned to help manage your new cloud platform from end to end with turnkey managed services. Our Azure Managed services offer cutting-edge capabilities to address your business needs.

## XAnge
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Software, SaaS, Information Technology

For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.

## Air Street Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Artificial Intelligence, Machine Learning, Biotechnology

Air Street Capital invests in AI-first technology and life science companies.

## Karista
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Biotechnology, Health Care

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

## Sofimac Investment Managers
- Type: VC Fund
- Location: Clermont-ferrand, Auvergne, France
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Manufacturing

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

## Partech
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 2
- Stages: Series A, Seed, Series B
- Focus: Software, E-Commerce, Financial Services

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

## JDRF T1D Fund
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

## Eutopia VC
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Retail, Food and Beverage, E-Commerce

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Siparex Groupe
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 2
- Stages: Private Equity, Seed
- Focus: Manufacturing, Software, Information Technology

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

## Point Nine
- Type: VC Fund
- Location: Berlin, Berlin, Germany
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, SaaS, Internet

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

## Shire
- Type: VC Fund
- Location: Dublin, Dublin, Ireland
- Relevant deals: 1
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Therapeutics, Biopharma

Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.

## Capital Grand Est
- Type: VC Fund
- Location: Schiltigheim, Alsace, France
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Computer

Capital Grand Est is a private equity firm that focuses on supporting businesses.
Capital Grand Est was founded in 2012 and was headquartered in Schiltigheim, France.

## Banque Populaire Group
- Type: VC Fund
- Location: Casablanca, Grand Casablanca, Morocco
- Relevant deals: 1
- Stages: Seed, Debt Financing
- Focus: Biopharma, Life Science, Biotechnology

Banque Populaire Group provides banking and credit services for individuals, international and corporate.

## IRDI SORIDEC Gestion
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Biotechnology, Information Technology, Software

IRDI SORIDEC Gestion

## Bioqube Ventures
- Type: VC Fund
- Location: Hasselt, Limburg, Belgium
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Life Science, Health Care

An early stage life science fund - investing in exciting science in vibrant European ecosystems to accelerate breakthrough therapies in patients.

## Angels Santé
- Type: VC Fund
- Location: Puteaux, Ile-de-France, France
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Health Care, Medical Device, Biotechnology

Angels Santé is a networking site for investors and companies in the health sector.

## Matignon Technologies
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Medical, Biotechnology, Medical Device

Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000and the Fund has a lifespan of six years.

## IXO Private Equity
- Type: VC Fund
- Location: Toulouse, Midi-Pyrenees, France
- Relevant deals: 1
- Stages: Private Equity, Series A
- Focus: Manufacturing, Software, Biotechnology

The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.

## Eli Lilly
- Type: VC Fund
- Location: Indianapolis, Indiana, United States
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Pharmaceutical

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It alsoconducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Products Neurosciences products, include Zyprexa, for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; Cymbalta, for the treatment of the major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, and in the United States for the management of fibromyalgia; Strattera, for the treatment of attention-deficit hyperactivity disorder in children, adolescents, and adults; Prozac, for the treatment of the major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and Symbyax, for the treatment of bipolar depression. Endocrinology products, include Humalog, Humalog Mix 75/25, and Humalog Mix 50/50tm, for the treatment of diabetes; Humulin, for the treatment of diabetes; Byetta, for the treatment of type 2 diabetes; Actos, for the treatment of type 2 diabetes; Evista, for the prevention and treatment of osteoporosis in postmenopausal women and for the reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer; Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture; and Humatrope, for the treatment of human growth hormone deficiency and idiopathic short stature.

## Calao Finance
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Information Technology, Software, Big Data

CALAO Finance is an independent private equity company, specialized in financing European SME.

## Credit Mutuel
- Type: VC Fund
- Location: Strasbourg, Alsace, France
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Finance, Financial Services, E-Commerce

Credit Mutuel is a French investment bank specialized in early stage venture investments.

## Roche Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.

## Afone Participations
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Compliance, Life Science

Afone Participations is a telecommunications and electronic payments company.

## ACG Management
- Type: VC Fund
- Location: Marseille, Provence-Alpes-Cote d'Azur, France
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Biotechnology

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

## Thai Union Ventures
- Type: VC Fund
- Location: Samut Sakhon, Samut Sakhon, Thailand
- Relevant deals: 1
- Stages: Series A
- Focus: Life Science, Biotechnology, Food Processing

Thai Union Ventures is a corporate venture arm of thai union group.

## Earlybird Venture Capital
- Type: VC Fund
- Location: Berlin, Berlin, Germany
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, Information Technology, Health Care

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.

## Agrinvest
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Software, Biotechnology, E-Commerce

Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.

## EIC-Fund
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Grant, Series A
- Focus: Information Technology, Health Care, Software

EIC offers investors the opportunity to co-invest in the most innovative start-ups and SMEs in the EU

## InnoBio Fund
- Type: VC Fund
- Location: Maisons-alfort, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Series C
- Focus: Biotechnology, Therapeutics, Health Care

InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.

## Lundbeckfonden Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

## Credit Agricole CIB
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Debt Financing, Series A, Series B
- Focus: Energy, Biotechnology, Health Care

Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.

## EIT Health
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 1
- Stages: Grant, Pre-Seed, Seed
- Focus: Health Care, Medical Device, Medical

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

## Amundi Private Equity Funds
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Private Equity, Series A
- Focus: Software, E-Commerce, Biotechnology

Amundi Private Equity Funds, an Amundi asset management subsidiary, specialises in private equity and unlisted infrastructure investments. Combining a wealth of expertise in all aspects of asset management built up over more than 10 years, Amundi provides both institutional and individual investors with a wide spectrum of investmentopportunities, ranging from direct fund investments in unlisted French and foreign companies to dedicated mandates and funds-of-funds for multi-management private equity and infrastructure investments. With more than 60 professionals based in Paris, Bucharest, Cairo, Casablanca, Tunis and Warsaw, Amundi Private Equity Funds assists companies at all stages of their development, the key objective being to offer fund subscribers yields in line with the best in the industry. At 31 December 2009, French and international subscribers had committed more than €3.7 billion to Amundi Private Equity Funds, making it a leading private equity player. The company owes its solid foundations to its positioning as part of a leading third-party asset management group of companies and to its membership of two international banking groups.

## Sofipaca
- Type: VC Fund
- Location: Aix-en-provence, Provence-Alpes-Cote d'Azur, France
- Relevant deals: 1
- Stages: Private Equity, Series A, Series B
- Focus: Food and Beverage, Pharmaceutical, Manufacturing

Sofipaca supports SMEs and mid-caps in the SOUTH region in the long term in their development capital and transmission capital operations.
The company was founded in 1984 and based in Aix en Provence, France.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co